CHMP recommends EU approval of Roche’s Vabysmo, the first bispecific antibody for the eye, for two leading causes of vision loss July 22, 2022July 30, 2022 by / Share This.....LinkedinTwitterFacebookGoogleEmailRelated News: European Commission approves Roche’s Vabysmo, the…CHMP recommends EU conditional approval of Roche’s…New two-year data confirm Roche’s Vabysmo improves…Positive topline phase III results show Roche's…New phase III data show Roche’s Vabysmo rapidly…CHMP recommends EU approval of Roche’s Polivy…
